Original Research ARTICLE
Higher cardiorespiratory fitness levels are associated with greater hippocampal volume in breast cancer survivors
- 1Department of Psychology, The Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, IL, USA
- 2Department of Behavioral Health and Nutrition, College of Health Sciences, University of Delaware, Newark, DE, USA
- 3School of Family and Consumer Sciences, Texas State University, San Marcos, TX, USA
- 4Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL, USA
- 5Department of Psychology, University of Pittsburgh, Pittsburgh, PA, USA
As breast cancer treatment is associated with declines in brain and cognitive health, it is important to identify strategies to enhance the cognitive vitality of cancer survivors. In particular, the hippocampus is known to play an important role in brain and memory declines following cancer treatment. The hippocampus is also known for its plasticity and positive association with cardiorespiratory fitness (CRF). The present study explores whether CRF may hold promise for lessening declines in brain and cognitive health of a sample of breast cancer survivors within 3 years of completion of primary cancer treatment. We explored the role of cardiovascular fitness in hippocampal structure in breast cancer survivors and non-cancer female controls, as well as performed a median split to compare differences in hippocampal volume in relatively higher fit and lower fit cancer survivors and non-cancer controls. Indeed, CRF and total hippocampal volume were positively correlated in the cancer survivors. In particular, higher fit breast cancer survivors had comparable hippocampal volumes to non-cancer control participants (Cohen’s d = 0.13; p > 0.3), whereas lower fit breast cancer survivors showed significantly smaller hippocampal volumes compared to both lower fit and higher fit control participants (Cohen’s d = 0.87, p < 0.05). These results are the first to identify that CRF may protect the brain health of breast cancer survivors within 3 years of treatment. The present study uniquely contributes to the field of cancer and cognition and emphasizes the importance of investigating how individual differences in CRF play a role in brain changes of breast cancer survivors.
Breast cancer treatment is associated with declines in brain and cognitive health (Pereira Dias et al., 2014). Decreases in performance on tasks of executive function, memory, learning, reasoning, concentration, and attention (Argyriou et al., 2011; Wefel et al., 2011) are often reported post-treatment in breast cancer survivors, coupled with declines in gray matter volume (de Ruiter et al., 2012), poorer white matter health (Ferguson et al., 2007; Abraham et al., 2008; Deprez et al., 2011), and altered brain function (Kesler et al., 2009, 2013b; de Ruiter et al., 2011; Bruno et al., 2012). Given an estimated 232,000 new cases of breast cancer diagnosed in the United States in 2013 (DeSantis et al., 2014), it is important to establish interventions to reduce the risk of these impairments and to enhance the cognitive vitality of breast cancer survivors.
The hippocampus, known for its plasticity, has been shown to play an important role in brain and memory declines following cancer treatment (Kesler et al., 2013a). Indeed, a number of human studies show that breast cancer survivors have smaller hippocampal volumes, which are associated with poorer memory performance, relative to women without cancer (McDonald et al., 2010; Bergouignan et al., 2011; de Ruiter et al., 2011; Kesler et al., 2013a). Animal models suggest that microenvironmental changes associated with cancer treatments may lead to the suppression of cell proliferation, neurogenesis, angiogenesis, and the release of neurotrophic factors in the hippocampus, thereby disrupting plasticity (Dietrich et al., 2006; Winocur et al., 2006; Seigers et al., 2008, 2009; Dietrich, 2010; Hyrien et al., 2010; Seigers and Fardell, 2011). For example, in rodents, administration of chemotherapy agents used for breast cancer have been associated with reduced hippocampal neurogenesis (Seigers et al., 2008; Janelsins et al., 2010), hippocampus-related cognitive deficits (Foley et al., 2008; Walker et al., 2011), and reduced levels of brain-derived neurotrophic factor (BDNF) in the hippocampus (Mustafa et al., 2008), a molecule known to be a mediator of neurogenesis and critical for memory formation (Figurov et al., 1996; Kang and Schuman, 1996; Pang et al., 2004). Radiation treatment has also been shown to impair cognition (Shibayama et al., 2014), decrease the production of new neurons, increase cell apoptosis in the hippocampus (Peissner et al., 1999; Tada et al., 2000; Monje et al., 2002), and disrupt microvascular angiogenesis (Monje et al., 2002; Villeda et al., 2011).
An important next step is to use this understanding of brain and cellular mechanisms to determine methods to offset declines in hippocampal structure and function in cancer survivors following treatment. Cardiorespiratory fitness (CRF) and aerobic exercise are known to positively contribute to neural plasticity of the hippocampus in humans. That is, younger and older healthy humans with higher CRF levels have larger hippocampal volumes (Erickson et al., 2009; Chaddock et al., 2010; Bugg and Head, 2011), and greater hippocampal volume mediates improvements in hippocampal memory (Erickson et al., 2009, 2011; Chaddock et al., 2010). However, it is unknown whether these associations extend to breast cancer survivors. In rodents, voluntary wheel running following chemotherapy or radiation has been found to result in restoration of cognitive function (Fardell et al., 2012), hippocampal neurogenesis (Naylor et al., 2008), levels of precursor cells (Naylor et al., 2008), and neurotrophic factors such as BDNF, insulin-like growth factor 1 (IGF-1), and vascular endothelial growth factor (VEGF; Wong-Goodrich et al., 2010). Thus, CRF may hold promise for improving brain and cognitive health of human cancer survivors following primary treatment.
In the present study, we predicted that CRF would buffer declines in hippocampal volume in women within 3 years of completion of primary cancer treatment (surgery, chemotherapy and/or radiation), such that breast cancer survivors with higher CRF would have comparable hippocampal volume to that of non-cancer control participants. We explored anterior and posterior subsections of the hippocampus to examine whether breast cancer status, and/or CRF, had selective effects on brain structure in breast cancer survivors. We also hypothesized that larger hippocampal volumes would be associated with better memory performance on a task that required the maintenance of a flexible and dynamic map of spatial information, a task considered to be dependent on the hippocampus (Watson et al., 2013). In particular, individuals with hippocampal amnesia have been found to display impaired performance on this task, such that they reversed, or “swapped,” the relative positions of learned item pairs during attempts to reconstruct object arrays (Watson et al., 2013). Here we explored whether structural differences in the hippocampus, both as a function of breast cancer status and CRF level, also predicted memory performance in terms of “swaps.”
Materials and Methods
Breast cancer survivors and non-cancer control participants were recruited from East-Central Illinois. To be eligible for the study, breast cancer survivors had to be within 3 years of completion of primary cancer treatment (surgery, chemotherapy and/or radiation; could still be on hormone therapy). Furthermore, participants with a history of stroke, transient ischemic attack, surgery that involved removal of brain tissue, a score ≤23 on the modified Mini-Mental Status Exam (MSSE), or current use of computer-based brain training games (e.g., Lumosity®, BrainHQ®) were excluded. The study was approved by the University of Illinois Institutional Review Board, and all participants provided informed consent. All participants also provided written consent from a physician prior to study enrollment indicating clearance to participate in both the CRF, cognitive, and MRI testing. The present study included 29 female breast cancer survivors (all non-Hispanics) and 27 female controls (25 non-Hispanics, 2 Hispanics).
Cardiorespiratory Fitness Assessment
CRF was assessed via a submaximal graded exercise treadmill test (Naughton protocol; Wasserman et al., 1999). After each participant was fitted with a heart rate monitor, he/she walked on a treadmill while speed and/or grade increased in 2 min stages until achieving 85% of a pre-determined, age-predicted maximum (220 age) heart rate. During each 2 min stage, heart rate, blood pressure, and subjective rating of perceived exertion were recorded. A 3 min monitored cool-down period of slower walking and a final 2 min monitored seated resting period were also included. CRF was derived from the treadmill test as an estimated V02 peak (American College of Sports Medicine, 2013).
Structural MRI Protocol
High resolution T1-weighted brain images were acquired using a 3D Magnetization Prepared Rapid Gradient Echo Imaging (MPRAGE) protocol with 192 contiguous axial slices, collected in ascending fashion parallel to the anterior and posterior commissures, echo time (TE) = 2.32 ms, repetition time (TR) = 1900 ms, field of view (FOV) = 230 mm, acquisition matrix 256 mm × 256 mm, slice thickness = 0.90 mm, and flip angle = 9°. All images were collected on a Siemens Magnetom Trio 3T whole-body MRI scanner.
FMRIB’s Integrated Registration and Segmentation Tool
Segmentation and volumetric analysis of the hippocampus were performed using a semi-automated, model-based subcortical tool (FMRIB’s Integrated Registration and Segmentation Tool; FIRST) in FMRIB’s Software Library (FSL) version 4.1.9 (Patenaude, 2007).
A two-stage affine registration to a standard space template (MNI space) with 1 mm resolution using 12-degrees of freedom and a subcortical mask to exclude voxels outside the subcortical regions was first performed on each participant’s MPRAGE. Next, the hippocampus was segmented with 30 modes of variation. To achieve accurate segmentation, the FIRST methodology models 317 manually segmented and labeled T1-brain images from normal children, adults, and pathological populations (obtained from the Center for Morphometric Analysis, Massachusetts General Hospital, Boston) as a point distribution model with the geometry and variation of the shape of each structure submitted as priors. Volumetric labels are parameterized by a 3D deformation of a surface model based on multivariate Gaussian assumptions. FIRST searches through linear combinations of shape modes of variation for the most probable shape (i.e., brain structure) given the intensity distribution in the T1-weighted image, and specific brain regions are extracted (see Patenaude et al., 2007a, b for further description of the method). Modes of variation are optimized based on leave-one-out cross-validation on the training set, and they increase the robustness and reliability of the results (Patenaude et al., 2007b). The segmentations were visually checked for errors. Finally, boundary correction was run, a process that classifies boundary voxels as belonging to the structure (or not) based on a statistical probability (z-score >3.00; p < 0.001). The volume of each participant’s brain region was measured in mm3 and converted to cm3 for presentation.
Anterior and posterior sections of the hippocampus were calculated by determining the center of gravity for both the left and right hippocampus for each participant. The y coordinate from the center-of-gravity calculation was used to divide the region into anterior and posterior sections, and the left and right volume of each anterior and posterior subsection was determined (Erickson et al., 2011).
Spatial Memory Task
We administered a spatial reconstruction task (Huttenlocher and Presson, 1979; Smith and Milner, 1981; Jeneson et al., 2010) to all participants. During each trial the participant studied an object array (containing five objects) and clicked on each object. Then, the objects disappeared and appeared aligned at the top of the screen. The participant was told to use the computer mouse to reconstruct the original spatial layout of the objects. Participants completed 25 trials. Figure 1 illustrates a “study” and “test” trial of the spatial memory task.
Figure 1. Illustration of sample “study” and “test” trial of the spatial memory task. During the “study” phase, the participant studied an object array. Then, the objects disappeared and appeared aligned at the top of the screen. During the “test” phase, the participant was told to use the computer mouse to reconstruct the original spatial layout of the objects.
We focused on errors made in reconstructing the relative positions of objects, known as “swaps.” “Swaps” occur when objects switch positions between study and reconstruction (i.e., when the correct locations were filled but with misassignment of particular objects to particular locations). Hippocampal amnesics have been found to show more “swaps” on this task, thereby failing at binding item identities to locations (Watson et al., 2013). We report “swaps” as the rate that a swap occurs (per pair of items).
Univariate ANCOVAs were conducted to compare hippocampal volume and memory performance as a function of group (breast cancer survivor, non-cancer control), with age as a covariate. Given the small sample size and exploratory nature of this study, we explored associations between CRF and hippocampal volume stratified by group. We also performed a median split based on fitness level in the cancer participants and control participants to compare hippocampal volumes between the higher fit and lower fit cancer survivors and the non-cancer controls using independent t-tests. That is, one median split stratified the breast cancer survivors into two groups: (1) a lower fit breast cancer group with CRF levels lower than, and including, the median; and (2) a higher fit breast cancer group, with CRF levels above the median. A median split analysis was also conducted for the non-cancer control group to create a lower fit and higher fit control group.
Effect sizes (Cohen’s d) were calculated and reported (Cohen, 2013). Cohen’s d is a measure of the distance between two means, measured in standard deviations (SD). The following was the formula used to calculate the Cohen’s d: d = (Mean1−Mean2)/SDpooled, SDpooled is the pooled standard deviation for the samples .
The present study included 29 female survivors of primary (stage I-IIIA) breast cancer who underwent surgery, adjuvant chemotherapy treatment and/or radiation treatment (N = 11 radiation only, N = 7 chemotherapy only, N = 11 radiation and chemotherapy). On average, the participants were 17 ± 9 months off-therapy (range = 2–33 months). Survivors were all disease and relapse free at the time of evaluation. We also included 27 non-cancer female controls. There were no significant differences between the groups in terms of age (range = 41–73 years), years of education, CRF or MSSE (all t < 0.5, p > 0.5; Table 1).
Table 1. Participant mean demographic, fitness, hippocampal volume, and memory data (SE) by group (breast cancer survivors, non-cancer controls; including p-values of independent t-tests and Cohen’s d).
Group, Hippocampal Volume, and Memory
All hippocampal volumes for breast cancer survivors and non-cancer control participants are shown in Table 1. Radiation only, chemotherapy only, and radiation and chemotherapy groups were combined into a “breast cancer survivor” group given no significant differences in total hippocampal volume (t < 1.8, p > 0.05) between specific cancer treatment groups. Breast cancer survivors had significantly smaller volumes in the left posterior hippocampus compared to non-cancer control participants (Table 1; F(1,53) = 5.48, p = 0.02; when controlling for age, which was associated with hippocampal volume, r = −0.273, p = 0.04). No group differences were found for anterior hippocampal volumes (all F < 1.9, p > 0.1) or total hippocampal volume (F(1,53) = 2.78, p = 0.10).
Although we predicted that breast cancer survivors would show more “swaps” on the spatial memory task, memory performance did not significantly differ between the groups (t(56) = 1.2, p = 0.2). An examination of the means suggest more “swaps” in the cancer patients (M = 0.08, SD = 0.06) compared to control participants (M = 0.06, SD = 0.05; Cohen’s d = 0.36). Additionally, more “swap” memory errors were associated with smaller left posterior hippocampal volumes (r = −0.27, p = 0.048; Figure 2), where the groups differed in brain volume.
Figure 2. More “swap” memory errors were associated with smaller left posterior hippocampal volumes (r = −0.27, p = 0.048), where the breast cancer survivors and non-cancer control participants differed in brain volume. “Swaps” occur when objects switch positions between study and reconstruction, and hippocampal amnesics have been found to show more “swaps” on this task (Watson et al., 2013).
CRF and total hippocampal volume were positively correlated (r = 0.351, p = 0.008). Within condition analyses indicated that this relationship remained significant in the cancer survivors (r = 0.374, p = 0.04), but not the control group (r = 0.307, p = 0.119; Figure 3).
Figure 3. Associations between CRF and hippocampal volume stratified by group (breast cancer survivor, non-cancer control) were explored. CRF and total hippocampal volume were positively correlated in the cancer survivors, but not the control group. *p < 0.05.
Next, we compared the hippocampal volumes of dichotomized higher fit and lower fit cancer survivors to the higher fit and lower fit control participants (Table 2; Figure 4). As predicted, higher fit cancer survivors did not show significant differences in total, anterior, and posterior hippocampal volume compared to lower fit or higher fit non-cancer control participants (all t < 0.9, all p > 0.3). Lower fit cancer survivors showed significantly smaller hippocampal volumes than higher fit control participants—in terms of total hippocampal volume (t(26) = 2.80, p = 0.010), anterior hippocampal volume (t(26) = 2.65, p = 0.014), and posterior hippocampal volume (t(26) = 2.79, p = 0.010). Lower fit cancer survivors also showed significantly smaller left posterior hippocampal volumes compared to lower fit control participants (t(27) = 2.39, p = 0.024). An effect size (Cohen’s d) of 0.87 suggested a large effect for the difference in total hippocampal volume between lower fit cancer survivors and control participants, with a negligible effect size (Cohen’s d = 0.13) for the difference in total hippocampal volume between higher fit cancer survivors and control participants.
Table 2. Participant mean demographic, fitness, hippocampal volume, and memory data (SE) by median split group (lower fit and higher fit breast cancer survivors, lower fit and higher fit non-cancer controls).
Figure 4. Hippocampal volumes of higher fit and lower fit cancer survivors and higher fit and lower fit control participants (as determined by a median split). Higher fit cancer survivors did not show significant differences in hippocampal volume compared to lower fit or higher fit non-cancer control participants (p > 0.3). Lower fit cancer survivors showed significantly smaller total hippocampal volumes than higher fit control participants (*p = 0.01).
CRF was not correlated with “swaps” on the spatial memory task in the cancer survivors (r = −0.024, p = 0.9) or control participants (r = −0.351, p = 0.07). Additionally, higher fit and lower fit cancer survivors did not differ from higher fit and lower fit control participants in terms of “swaps” (Table 2).
As one in eight women will develop breast cancer over the course of her lifetime (DeSantis et al., 2014), understanding changes in brain and cognitive health following cancer treatment, as well as approaches to improve cancer recovery, are of public health importance. The present study is the first to report that higher fit breast cancer survivors did not show significant differences in hippocampal volume compared to non-cancer control participants, whereas lower fit breast cancer survivors showed significantly smaller hippocampal volumes compared to both lower fit and higher fit control participants. Consequently, these results raise the possibility that the protective effects of CRF on hippocampal structure in healthy adults (Erickson et al., 2009; Bugg and Head, 2011) extend to cancer survivors.
The present study also supports previous findings of smaller hippocampal volumes in breast cancer survivors particularly in the left (Nakano et al., 2002; Kesler et al., 2013a) and posterior (Bergouignan et al., 2011) hippocampus. Further, despite no significant group differences on the memory task (Cohen’s d = 0.36), smaller left posterior hippocampal volumes were associated with poorer memory performance on a spatial learning task of hippocampal function (as also suggested in Bergouignan et al., 2011). It is interesting to note that although only left posterior hippocampal volume differed between cancer and control groups, CRF helped offset hippocampal volume declines across the total hippocampus, in both anterior and posterior subsections. Aerobic exercise has been found to selectively increase the volume of the anterior hippocampus that includes the dentate gyrus, where cell proliferation occurs (van Praag et al., 2005; Li et al., 2008; Creer et al., 2010; Erickson et al., 2011). The posterior hippocampus has not yet been linked to CRF or exercise, but this area is known to play a role in spatial learning and memory (Moser et al., 1993; Colombo et al., 1998; Maguire et al., 2000; Bannerman et al., 2004), which are cognitive abilities influenced by CRF (Erickson et al., 2009) and aerobic exercise (Cotman and Berchtold, 2002; Erickson et al., 2011). The posterior hippocampus also plays a role in depression and post-traumatic stress disorders, two conditions found in cancer survivors (de Geus et al., 2007; Maller et al., 2007; Bonne et al., 2008; Bergouignan et al., 2011).
Although promising, these results must be viewed cautiously given our a priori predictions and the relatively small sample size. Nevertheless, the effect sizes (Cohen’s d = 0.87 [difference in total hippocampal volume between lower fit cancer survivors and control participants], and Cohen’s d = 0.13 [difference in total hippocampal volume between higher fit cancer survivors and control participants]) suggest the importance of investigating how individual differences in CRF play a role in brain changes of breast cancer survivors. The results also parallel animal research demonstrating that wheel running following chemotherapy or radiation (one week to one month post-treatment) restores hippocampal brain health (Naylor et al., 2008; Wong-Goodrich et al., 2010; Fardell et al., 2012). As cancer treatments such as chemotherapy and radiation are known to target cell proliferation, neurogenesis, and vascularization in the hippocampus (Pereira Dias et al., 2014), the same cascades known to relate to CRF in rodent models of wheel running, it seems possible that CRF may play a role in these brain changes following cancer treatment in humans too.
The present investigation provides a foundation for exploring associations among CRF, hippocampal volume, and memory in cancer survivors and supports the need for randomized, controlled trials to establish causal associations among participation in physical activity aimed to improve CRF, brain structure and cognition in cancer patients. It would be interesting to collect CRF and hippocampal volume data before, during, and after breast cancer therapy to understand how indices of physical and cognitive health change from cancer diagnosis to post-treatment. Unfortunately, older breast cancer patients (age = 55 years) have been found to show impaired CRF (e.g., 27% lower than age-matched controls) across the survivorship continuum (Jones et al., 2012; Lakoski et al., 2013), further emphasizing the importance of investigating the role of physical activity during cancer recovery. In fact, as a variety of lifestyle and health-related behaviors influence hippocampal size and function (e.g., sleep, nutrition), it would be interesting to explore the role of other lifestyle factors in cancer recovery too (Pereira Dias et al., 2014).
Future work may also investigate how CRF moderates other structural and functional brain changes following cancer treatment. In addition to changes in hippocampal volume following cancer treatment, post-treatment declines in gray matter volume (de Ruiter et al., 2012), white matter tract integrity (Abraham et al., 2008; Deprez et al., 2011), white matter hyperintensities (Ferguson et al., 2007) as well as altered brain activation during memory tasks (Kesler et al., 2009; de Ruiter et al., 2011) and resting state networks (Bruno et al., 2012; Kesler et al., 2013b) have been found to account for cancer-related cognitive declines. Whether higher levels of CRF are protective against these brain changes remains to be determined. Moreover, as our sample was heterogeneous in terms of disease, host and treatment variables, which is typical across the literature, it would be interesting to explore how specific treatment regimens are associated with fitness-related changes in brain structure.
In conclusion, the present study is the first to identify that CRF holds promise for improving the brain health of breast cancer survivors within 3 years of completion of treatment. Our findings also support further research on the inclusion of physical activity, aimed to improve CRF, in treatment protocols for breast cancer survivors.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Abraham, J., Haut, M. W., Moran, M. T., Filburn, S., Lemiuex, S., and Kuwabara, H. (2008). Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging. Clin. Breast Cancer 8, 88–91. doi: 10.3816/cbc.2008.n.007
Argyriou, A. A., Assimakopoulos, K., Iconomou, G., Giannakopoulou, F., and Kalofonos, H. P. (2011). Either called “chemobrain” or “chemofog,” the long-term chemotherapy-induced cognitive decline in cancer survivors is real. J. Pain Symptom Manage. 41, 126–139. doi: 10.1016/j.jpainsymman.2010.04.021
Bannerman, D. M., Rawlins, J. N., McHugh, S. B., Deacon, R. M., Yee, B. K., Bast, T., et al. (2004). Regional dissociations within the hippocampus—memory and anxiety. Neurosci. Biobehav. Rev. 28, 273–283. doi: 10.1016/j.neubiorev.2004.03.004
Bergouignan, L., Lefranc, J. P., Chupin, M., Morel, N., Spano, J. P., and Fossati, P. (2011). Breast cancer affects both the hippocampus volume and the episodic autobiographical memory retrieval. PLoS One 6:e25349. doi: 10.1371/journal.pone.0025349
Bonne, O., Vythilingam, M., Inagaki, M., Wood, S., Neumeister, A., Nugent, A. C., et al. (2008). Reduced posterior hippocampal volume in posttraumatic stress disorder. J. Clin. Psychiat. 69, 1087–1091. doi: 10.4088/jcp.v69n0707
Bruno, J., Hosseini, S. M., and Kesler, S. (2012). Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors. Neurobiol. Dis. 48, 329–338. doi: 10.1016/j.nbd.2012.07.009
Chaddock, L., Erickson, K. I., Prakash, R. S., Kim, J. S., Voss, M. W., VanPatter, M., et al. (2010). A neuroimaging investigation of the association between aerobic fitness, hippocampal volume and memory performance in preadolescent children. Brain Res. 1358, 172–183. doi: 10.1016/j.brainres.2010.08.049
Creer, D. J., Romberg, C., Saksida, L. M., van Praag, H., and Bussey, T. J. (2010). Running enhances spatial pattern separation in mice. Proc. Natl. Acad. Sci. U S A 107, 2367–2372. doi: 10.1073/pnas.0911725107
de Geus, E. J., van’t Ent, D., Wolfensberger, S. P., Heutink, P., Witte, J. G., Hoogendijk, W. J., et al. (2007). Intrapair differences in hippocampal volume in monozygotic twins discordant for the risk for anxiety and depression. Biol. Psychiatry 61, 1062–1071. doi: 10.1016/j.biopsych.2006.07.026
Deprez, S., Amant, F., Yigit, R., Porke, K., Verhoeven, J., Van den Stock, J., et al. (2011). Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum. Brain Mapp. 32, 480–493. doi: 10.1002/hbm.21033
de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., Caan, M., Douaud, G., et al. (2012). Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum. Brain Mapp. 33, 2971–2983. doi: 10.1002/hbm.21422
de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., van Dam, F. S., Nederveen, A. J., et al. (2011). Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum. Brain Mapp. 32, 1206–1219. doi: 10.1002/hbm.21102
Dietrich, J., Han, R., Yang, Y., Mayer-Pröschel, M., and Noble, M. (2006). CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J. Biol. 5:22. doi: 10.1186/jbiol50
Erickson, K. I., Prakash, R. S., Voss, M. W., Chaddock, L., Hu, L., Morris, K. S., et al. (2009). Aerobic fitness is associated with hippocampal volume in elderly humans. Hippocampus 19, 1030–1039. doi: 10.1002/hipo.20547
Erickson, K. I., Voss, M. W., Prakash, R. S., Basak, C., Szabo, A., Chaddock, L., et al. (2011). Exercise training increases size of the hippocampus and improves memory. Proc. Natl. Acad. Sci. U S A 108, 3017–3022. doi: 10.1073/pnas.1015950108
Fardell, J. E., Vardy, J., Shah, J. D., and Johnston, I. N. (2012). Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity. Psychopharmacology (Berl) 220, 183–193. doi: 10.1007/s00213-011-2466-2
Ferguson, R. J., McDonald, B. C., Saykin, A. J., and Ahles, T. A. (2007). Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J. Clin. Oncol. 25, 3866–3870. doi: 10.1200/jco.2007.10.8639
Figurov, A., Pozzo-Miller, L. D., Olafsson, P., Wang, T., and Lu, B. (1996). Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 381, 706–709. doi: 10.1038/381706a0
Foley, J. J., Raffa, R. B., and Walker, E. A. (2008). Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory. Psychopharmacology (Berl) 199, 527–538. doi: 10.1007/s00213-008-1175-y
Hyrien, O., Dietrich, J., and Noble, M. (2010). Mathematical and experimental approaches to identify and predict the effects of chemotherapy on neuroglial precursors. Cancer Res. 70, 10051–10059. doi: 10.1158/0008-5472.can-10-1400
Janelsins, M. C., Roscoe, J. A., Berg, M. J., Thompson, B. D., Gallagher, M. J., Morrow, G. R., et al. (2010). IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice. Cancer Invest. 28, 544–553. doi: 10.3109/07357900903405942
Jeneson, A., Mauldin, K. N., and Squire, L. R. (2010). Intact working memory for relational information after medial temporal lobe damage. J. Neurosci. 30, 13624–13629. doi: 10.1523/jneurosci.2895-10.2010
Jones, L. W., Courneya, K. S., Mackey, J. R., Muss, H. B., Pituskin, E. N., Scott, J. M., et al. (2012). Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum. J. Clin. Oncol. 30, 2530–2537. doi: 10.1200/jco.2011.39.9014
Kesler, S. R., Bennett, F. C., Mahaffey, M. L., and Spiegel, D. (2009). Regional brain activation during verbal declarative memory in metastatic breast cancer. Clin. Cancer Res. 15, 6665–6673. doi: 10.1158/1078-0432.ccr-09-1227
Kesler, S., Janelsins, M., Koovakkattu, D., Palesh, O., Mustian, K., Morrow, G., et al. (2013a). Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav. Immun. 30, S109–S116. doi: 10.1016/j.bbi.2012.05.017
Kesler, S. R., Wefel, J. S., Hosseini, S. M., Cheung, M., Watson, C. L., and Hoeft, F. (2013b). Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls. Proc. Natl. Acad. Sci. U S A 110, 11600–11605. doi: 10.1073/pnas.1214551110
Lakoski, S. G., Barlow, C. E., Koelwyn, G. J., Hornsby, W. E., Hernandez, J., Defina, L. F., et al. (2013). The influence of adjuvant therapy on cardiorespiratory fitness in early-stage breast cancer seven years after diagnosis: the cooper center longitudinal study. Breast Cancer Res. Treat. 138, 909–916. doi: 10.1007/s10549-013-2478-1
Li, Y., Luikart, B. W., Birnbaum, S., Chen, J., Hyuk, C. K., Kernie, S. G., et al. (2008). TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron 59, 399–412. doi: 10.1016/j.neuron.2008.06.023
Maguire, E. A., Gadian, D. G., Johnsrude, I. S., Good, C. D., Ashburner, J., Frackowiak, R. S. J., et al. (2000). Navigation-related structural change in the hippocampi of taxi drivers. Proc. Natl. Acad. Sci. U S A 97, 4398–4403. doi: 10.1073/pnas.070039597
McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., and Saykin, A. J. (2010). Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res. Treat. 123, 819–828. doi: 10.1007/s10549-010-1088-4
Moser, E. I., Moser, M. B., and Andersen, P. (1993). Spatial learning impairment parallels the magnitude of dorsal hippocampal lesions, but is hardly present following ventral lesions. J. Neurosci. 13, 3916–3925.
Mustafa, S., Walker, A., Bennett, G., and Wigmore, P. M. (2008). 5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus. Eur. J. Neurosci. 28, 323–330. doi: 10.1111/j.1460-9568.2008.06325.x
Nakano, T., Wenner, M., Inagaki, M., Kugaya, A., Akechi, T., Matsuoka, Y., et al. (2002). Relationship between distressing cancer-related recollections and hippocampal volume in cancer survivors. Am. J. Psychiatry 159, 2087–2093. doi: 10.1176/appi.ajp.159.12.2087
Naylor, A. S., Bull, C., Nilsson, M. K., Zhu, C., Björk-Eriksson, T., Eriksson, P. S., et al. (2008). Voluntary running rescues adult hippocampal neurogenesis after irradiation of the young mouse brain. Proc. Natl. Acad. Sci. U S A 105, 14632–14637. doi: 10.1073/pnas.0711128105
Pang, P. T., Teng, H. K., Zaitsev, E., Woo, N. T., Sakata, K., Zhen, S., et al. (2004). Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306, 487–491. doi: 10.1126/science.1100135
Peissner, W., Kocher, M., Treuer, H., and Gillardon, F. (1999). Ionizing radiation-induced apoptosis of proliferating stem cells in the dentate gyrus of the adult rat hippocampus. Brain Res. Mol. Brain Res. 71, 61–68. doi: 10.1016/s0169-328x(99)00170-9
Pereira Dias, G., Hollywood, R., Bevilaqua, M. C., da Luz, A. C., Hindges, R., Nardi, A. E., et al. (2014). Consequences of cancer treatments on adult hippocampal neurogenesis: implications for cognitive function and depressive symptoms. Neuro Oncol. 16, 476–492. doi: 10.1093/neuonc/not321
Seigers, R., and Fardell, J. E. (2011). Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research. Neurosci. Biobehav. Rev. 35, 729–741. doi: 10.1016/j.neubiorev.2010.09.006
Seigers, R., Schagen, S. B., Beerling, W., Boogerd, W., van Tellingen, O., van Dam, F. S., et al. (2008). Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav. Brain Res. 186, 168–175. doi: 10.1016/j.bbr.2007.08.004
Seigers, R., Schagen, S. B., Coppens, C. M., van der Most, P. J., van Dam, F. S., Koolhaas, J. M., et al. (2009). Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats. Behav. Brain Res. 201, 279–284. doi: 10.1016/j.bbr.2009.02.025
Shibayama, O., Yoshiuchi, K., Inagaki, M., Matsuoka, Y., Yoshikawa, E., Sugawara, Y., et al. (2014). Association between adjuvant regional radiotherapy and cognitive function in breast cancer patients treated with conservation therapy. Cancer Med. 3, 702–709. doi: 10.1002/cam4.174
Tada, E., Parent, J. M., Lowenstein, D. H., and Fike, J. R. (2000). X-irradiation causes a prolonged reduction in cell proliferation in the dentate gyrus of adult rats. Neuroscience 99, 33–41. doi: 10.1016/s0306-4522(00)00151-2
Villeda, S., Luo, J., Mosher, K. I., Bende, Z., Britschgi, M., Bieri, G., et al. (2011). The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477, 90–94. doi: 10.1038/nature10357
Walker, E., Foley, J. J., Clark-Vetri, R., and Raffa, R. B. (2011). Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate and 5-fluorouracil on the acquisition and retention of a learned response in mice. Psychopharmacology (Berl) 217, 539–548. doi: 10.1007/s00213-011-2310-8
Wasserman, K., Hansen, J. E., Sue, D. Y., Casaburi, R., and Whipp, B. J. (1999). Principles of Exercise Testing and Interpretation: Including Pathophysiology and Clinical Applications. Philadelphia, PA: Lippincott, Williams & Wilkins.
Watson, P. D., Voss, J. L., Warren, D. E., Tranel, D., and Cohen, N. J. (2013). Spatial reconstruction by patients with hippocampal damage is dominated by relational memory errors. Hippocampus 23, 570–580. doi: 10.1002/hipo.22115
Wefel, J. S., Vardy, J., Ahles, T., and Schagen, S. B. (2011). International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 12, 703–708. doi: 10.1016/s1470-2045(10)70294-1
Winocur, G., Vardy, J., Binns, M. A., Kerr, L., and Tannock, I. (2006). The effects of the anti- cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. Pharmacol. Biochem. Behav. 85, 66–75. doi: 10.1016/j.pbb.2006.07.010
Wong-Goodrich, S., Pfau, M. L., Flores, C. T., Fraser, J. A., Williams, C. L., and Jones, L. W. (2010). Voluntary running prevents progressive memory decline and increases adult hippocampal neurogenesis and growth factor expression after whole-brain irradiation. Cancer Res. 70, 9329–9338. doi: 10.1158/0008-5472.can-10-1854
Keywords: aerobic fitness, brain, cancer treatment, memory, physical activity
Citation: Chaddock-Heyman L, Mackenzie MJ, Zuniga K, Cooke GE, Awick E, Roberts S, Erickson KI, McAuley E and Kramer AF (2015) Higher cardiorespiratory fitness levels are associated with greater hippocampal volume in breast cancer survivors. Front. Hum. Neurosci. 9:465. doi: 10.3389/fnhum.2015.00465
Received: 24 February 2015; Accepted: 10 August 2015;
Published: 26 August 2015.
Edited by:Francesco Di Russo, University of Rome “Foro Italico”, Italy
Reviewed by:Nora L. Nock, Case Western Reserve University, USA
Christina Tognoni, Duke University, USA
Copyright © 2015 Chaddock-Heyman, Mackenzie, Zuniga, Cooke, Awick, Roberts, Erickson, McAuley and Kramer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Laura Chaddock-Heyman, Department of Psychology, The Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, 405 North Mathews Avenue, Urbana, IL 61801, USA, email@example.com